fbpx

Persistent Pain

Hero image_Persistent pain

An estimated 3.4 million Australians are living with persistent pain.1 Pain significantly affects a person’s quality of life and is associated with increased disability and high levels of psychological distress, anxiety and depression.2,3 

 

The below resources and activities have been specifically designed for pharmacists to assist people to think differently about persistent pain by addressing their thoughts and feelings and identifying when medicines may, or may not, be of benefit.  

Resources and activities

Link to Persistent Pain webinar registration

REGISTER for the  LIVE webinar: Persistent Pain- optimise patient function through multidisciplinary care. Wednesday 5th June 2024; 7.00 – 8.00 AEST. 

REGISTER NOW
Link to Pharmacist Quick Reference Guide on Cumulative Medicines

Access the Pharmacist Quick Reference Guide: Persistent Pain
Coming soon

Link to Pharmacist Case Series

Access the  Pharmacist Case Series: Pharmacist Case Series: Supporting patients with persistent pain. Coming soon

References: 

1. Painaustralia. Painful Facts. 2020. At: https://www.painaustralia.org.au/about-pain/painaustralia-painful-facts 

2. Kroenke K, Outcalt S, Krebs E, Bair M, Wu J, Chumbler N et al. Association between anxiety, health-related quality of life and functional impairment in primary care patients with chronic pain. Gen Hosp Psychiatry. 2013; 35(4): 359-365.   

3. Holmes A, Christelis N, Arnold C. Depression and chronic pain. Med J Aust. 2013; 199(S6): S17-20. 

Medicines Advice Initiative Australia (MAIA) is provided to you by University of South Australia Quality Use of Medicines and Pharmacy Research Centre | In association with: Australian Medicines Handbook (AMH) | Drug and Therapeutics Information Service (DATIS) | Discipline of General Practice, University of Adelaide | National Aboriginal Community Controlled Health Organisation (NACCHO) | Pharmaceutical Society of Australia (PSA) | Council of Australian Therapeutic Advisory Groups (CATAG).  
MAIA is funded by the Australian Government through the Quality Use of Diagnostics, Therapeutics and Pathology Program. 
MAIA materials are adapted from the Veterans’ MATES program materials.  “This material is used under licence from the Australian Government, © Commonwealth of Australia, Department of Veterans’ Affairs 2023”. The views expressed in the MAIA materials do not necessarily represent the views of the Minister for Veterans’ Affairs or the Department of Veterans’ Affairs.  The Commonwealth does not give any warranty nor accept any liability in relation to the content or use of this material.”  
Department of veteran affairs logo

The Pharmaceutical Society of Australia (PSA) is the peak national professional pharmacy organisation, representing Australia's 37,000+ pharmacists in all sectors and across all locations, working in or towards a career in pharmacy. Registered training organisation code: 122206 ABN:49 008 532 072 ACN:008 532 072

In the spirit of reconciliation, the Pharmaceutical Society of Australia (PSA) acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today. We recognise that Aboriginal and Torres Strait Islander peoples were our first pharmacists.

© 2024 Pharmaceutical Society of Australia Ltd. All rights reserved.